Molecular mechanisms of antithrombin deficiency in two Chinese families

被引:11
作者
Zhou, RF
Fu, QH
Wang, WB
Xie, S
Dai, J
Ding, QL
Wang, XF
Wang, HL
Wang, ZY
机构
[1] Shanghai Med Univ 2, Ruijin Hosp, Shanghai Inst Hematol, Div Thrombosis & Hemostasis, Shanghai 200025, Peoples R China
[2] Nanjing Univ, Drum Tower Hosp, Div Hematol, Nanjing 210008, Jiangsu Prov, Peoples R China
[3] Blood Ctr Zhejiang Prov, Inst Transfus Med, Hangzhou, Zhejiang, Peoples R China
关键词
antithrombin deficiency; gene mutation; venous thrombosis;
D O I
10.1160/TH05-06-0450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the molecular mechanisms responsible for type I congenital antithrombin (AT) deficiency in two unrelated Chinese pedigrees manifesting multiple site venous thrombosis. Phenotype analysis showed both probands had almost 50% of normal AT levels. Direct sequencing of amplified DNA revealed 2757C > T in proband I and 13328G > A in proband 2, predicting a heterozygous Thi-98lle (T981) and AIa404Thr (A404T), respectively. No proband had 20210A allele or factorV Leiden mutation. Transient expression of complementary DNA coding for the mutations in COS-7 cells showed impaired secretion of the mutant molecules. Real-time quantitative PCR indicated that the mutant AT mRNA was transcribed at a similar or even higher level as that of wild-type (wt). Pulse-chase labeling studies suggested both AT variants did not accumulate, but degraded intracellularly. lmmunohistochemical staining of the transfected cells revealed that CHO cells expressing the AT-198 mutant were stained diffusely without perinuclear enhancement and cells expressing AT-T404 mutant mainly in the whole cytoplasm with weaker perinuclear enhancement. We conclude that the impaired secretion of the mutant AT molecules, due to intracellular degradation, is the molecular pathogenesis of AT deficiency caused by T981 and A404T mutation for the two families, respectively.
引用
收藏
页码:1172 / 1176
页数:5
相关论文
共 16 条
[11]   INTRACELLULAR EVENTS DETERMINE THE FATE OF ANTITHROMBIN UTAH [J].
SHEFFIELD, WP ;
CASTILLO, JE ;
BLAJCHMAN, MA .
BLOOD, 1995, 86 (09) :3461-3467
[12]   Cellular and functional characterization of three recombinant antithrombin mutants that caused pleiotropic effect-type deficiency [J].
Shirotani, H ;
Tokunaga, F ;
Koide, T .
JOURNAL OF BIOCHEMISTRY, 1999, 125 (02) :253-262
[13]   The 2.6 angstrom structure of antithrombin indicates a conformational change at the heparin binding site [J].
Skinner, R ;
Abrahams, JP ;
Whisstock, JC ;
Lesk, AM ;
Carrell, RW ;
Wardell, MR .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 266 (03) :601-609
[14]   Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors [J].
Tokunaga, F ;
Shirotani, H ;
Hara, K ;
Kozuki, D ;
Omura, S ;
Koide, T .
FEBS LETTERS, 1997, 412 (01) :65-69
[15]   CRUCIAL RESIDUES IN THE CARBOXY-TERMINAL END OF C1 INHIBITOR REVEALED BY PATHOGENIC MUTANTS IMPAIRED IN SECRETION OR FUNCTION [J].
VERPY, E ;
COUTURETOSI, E ;
ELDERING, E ;
LOPEZTRASCASA, M ;
SPATH, P ;
MEO, T ;
TOSI, M .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :350-359
[16]  
WENBIN W, 2005, BLOOD COAGUL FIBRIN, V16, P149